About Mankind Prime Labs Private Limited
Data last updated:
Mankind Prime Labs Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Mankind Pharma Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2020PTC370864. Its GSTIN is 07AANCM8685M1ZF (Delhi). The company holds 22 GST registrations, of which 21 are active.
The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹100 Cr. It is led by directors including Rabindra Nath Choudhary (Whole-Time Director) and Abhay Kumar Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹332.48 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹20.19 Cr (net margin 6.1%) and EBITDA of ₹28.61 Cr (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.
The company has about 218 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹100 Cr on record. Court records list 13 cases involving the company, including 12 filed by the company and 1 filed against it; 8 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹74.5 Cr; the latest was in May 2021. Its 7 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 4 smaller; the largest is Abs Mercantiles Private Limited with revenue of ₹342.03 Cr.
For more details, the company can be reached via its website mankindpharma.com.
Company details
Contact details
Mankind Prime Labs Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered Address208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Mankind Prime Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mankind Prime Labs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mankind Prime Labs Private Limited, buy the company report.
Financials of Mankind Prime Labs Private Limited
FY 2025 filings availableMankind Prime Labs Private Limited reported revenue of ₹332.48 Cr (up 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 24% over three years, including 29% growth in the latest year. EBITDA rose 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.61 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | ||||
| Net Profit Margin | 6.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mankind Prime Labs Private Limited, buy the company report.
Board of directors and KMP of Mankind Prime Labs Private Limited
Mankind Prime Labs Private Limited currently reports 3 directors and 2 key managerial personnel. 3 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhay Kumar Srivastava Also directs: Sirmour Remedies Private Limited, Mankind Medicare Private Limited, Mankind Life Sciences Private Limited and 5 more | Director | 30 Jun 2021 | 5 Years 4 Months | Current |
| Akhlas Ahmed Also directs: Sirmour Remedies Private Limited, Mankind Medicare Private Limited, Mankind Life Sciences Private Limited and 5 more | Director | 26 Nov 2020 | 5 Years 11 Months | Current |
| Sumit Dhawan | Company Secretary | 15 Oct 2021 | 5 Years 0 Months | Current |
| Rabindra Nath Choudhary | Whole-Time Director | 07 Jul 2025 | 1 Years 4 Months | Current |
| Deepak Gupta | Cfo | 29 Feb 2024 | 2 Years 8 Months | Current |
Peer comparison
Mankind Prime Labs Private Limited is compared with the 7 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abs Mercantiles Private Limited | ₹342.03 Cr (FY 2025) | 8.0% | Gurgaon, Haryana, India | |||
| Zimmer India Private Limited | ₹339.74 Cr (FY 2025) | 11.0% | Gurgaon, Haryana, India | |||
| Parkleton Private Limited | ₹339.03 Cr (FY 2025) | -1.0% | Delhi, India | |||
| Mankind Prime Labs Private Limitedthis company | ₹332.48 Cr (FY 2025) | ₹20.19 Cr | 6.1% | 29.0% | 218 | New Delhi, Delhi, India |
| Konica Minolta Healthcare India Private Limited | ₹332.02 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Eastern Agencies Healthcare Private Limited | ₹324.45 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Innvolution Healthcare Private Limited | ₹323.31 Cr (FY 2025) | 13.0% | Bangalore, Karnataka, India | |||
| Avik Televentures Private Limited | ₹322.36 Cr (FY 2025) | 5.0% | New Delhi, Delhi, India |
To see the full peer comparison of Mankind Prime Labs Private Limited, buy the company report.
Auditor
Mankind Prime Labs Private Limited is audited by Bhagi Bhardwaj Gaur & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Bhagi Bhardwaj Gaur & Co. | FY 2023 | 007895N |
Shareholding
The shareholding of Mankind Prime Labs Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Mankind Prime Labs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2025 | 101173485 | Hdfc Bank Limited | ₹50 Cr | Open | |
| 18 Aug 2025 | 101152093 | Others | ₹50 Cr | Open |
Total charge records: 2 View all charges
Deals & funding
Mankind Prime Labs Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹74.5 Cr; the latest was in May 2021.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2021 | Funding round | ₹74.5 Cr | Investors: Mankind Pharma Limited |
| Nov 2020 | Secondary share transfer | Undisclosed | Buyer: Mankind Pharma Limited & Arjun Juneja, Mankind Pharma Limited Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Mankind Prime Labs Private Limited has 13 court cases on record: 12 filed by Mankind Prime Labs, 1 filed against it. 8 cases are pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 11 | 0 | 6 |
| District courts | 2 | 1 | 2 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed by the company against Ytiliga Private Limited & Anr. | Pending |
| Bombay High Court | Court case (COMMP) | Filed by the company against Jyothy Labs Limited | Pending |
| District court, Jaipur Metro I, Rajasthan | Civil miscellaneous application | Filed against the company by individuals | Pending |
| District court, South East, Delhi | Criminal case | Filed by the company against an individual | Pending |
| High Court of Delhi | Court case (C.A.(COMM.IPD-TM)) | Filed by the company against Registrar of Trade Marks | Pending |
To see the full case history of Mankind Prime Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mankind Prime Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Mankind Prime Labs Private Limited has a workforce of 218 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Mankind Prime Labs has 22 GST registrations: 21 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AANCM8685M1ZF | Delhi | Active | 14 Nov 2020 |
| 07AANCM8685M2ZE | Delhi | Active | 08 Jul 2021 |
| 09AANCM8685M1ZB | Uttar Pradesh | Active | 18 Nov 2020 |
| 06AANCM8685M1ZH | Haryana | Active | 17 Feb 2021 |
To see the full GST registrations and return filing status of Mankind Prime Labs Private Limited, buy the company report.
Recent activity
Mankind Prime Labs Private Limited has 9 board changes on record since 2020: 7 appointments and 2 cessations. The latest: Rabindra Nath Choudhary was appointed as Whole-Time Director on 07 Jul 2025.
2 earlier events are in the company report.
News
Frequently asked questions
Mankind Prime Labs is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 October 2020 (6+ years old) and is registered under CIN U51909DL2020PTC370864.
Mankind Prime Labs has 5 current directors and KMP:
- Rabindra Nath Choudhary - Whole-Time Director
- Abhay Kumar Srivastava - Director
- Akhlas Ahmed - Director
- Sumit Dhawan - Company Secretary
- Deepak Gupta - Cfo
The latest financial statements of Mankind Prime Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Mankind Prime Labs is 07AANCM8685M1ZF, registered in Delhi. The company has 22 GST registrations in all, of which 21 are active and 1 is cancelled or inactive. Other active GSTINs include 07AANCM8685M2ZE (Delhi), 09AANCM8685M1ZB (Uttar Pradesh), 06AANCM8685M1ZH (Haryana).
The CIN (Corporate Identification Number) of Mankind Prime Labs is U51909DL2020PTC370864. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mankind Prime Labs has 13 court cases on record: 12 filed by the company and 1 filed against it. 8 are pending. Most are in the high courts.
Mankind Prime Labs was incorporated on 03 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Mankind Prime Labs has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹74.5 Cr; the latest was in May 2021.
The peers of Mankind Prime Labs by revenue are Abs Mercantiles Private Limited, Zimmer India Private Limited, Parkleton Private Limited, Konica Minolta Healthcare India Private Limited, Eastern Agencies Healthcare Private Limited and 2 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rabindra Nath Choudhary was appointed as Whole-Time Director on 07 Jul 2025. Satender Singh ceased to be Director on 01 Jun 2025. Deepak Gupta was appointed as CFO on 29 Feb 2024. Mankind Prime Labs has 9 board changes on record in total.
Mankind Prime Labs can be reached through the website mankindpharma.com. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
